Journal of Organic Chemistry 2010-06-18

Scalable synthesis of a prostaglandin EP4 receptor antagonist.

Danny Gauvreau, Sarah J Dolman, Greg Hughes, Paul D O'Shea, Ian W Davies

Index: J. Org. Chem. 75(12) , 4078-85, (2010)

Full Text: HTML

Abstract

The evolution of scalable, economically viable synthetic approaches to the potent and selective prostaglandin EP4 antagonist 1 is presented. The chromatography-free synthesis of multikilogram quantities of 1 using a seven-step sequence (six in the longest linear sequence) is described. This approach has been further modified in an effort to identify a long-term manufacturing route. Our final synthesis involves no step requiring cryogenic (< -25 degrees C) conditions; comprises a total of four steps, only three of which are in the longest linear synthesis; and features the use of two consecutive iron-catalyzed Friedel-Crafts substitutions.

Related Compounds

  • Cyclopropanamine

Related Articles:

Synthesis and antibacterial activity of some novel 4-oxopyrido[2,3-a]phenothiazines.

2014-11-01

[Arch. Pharm. (Weinheim) 347(11) , 861-72, (2014)]

Cyclopropylamines from N,N-dialkylcarboxamides and Grignard reagents in the presence of titanium tetraisopropoxide or methyltitanium triisopropoxide.

2010-12-10

[Chemistry 16 , 13862-13875, (2010)]

Cyclopropylamine inactivation of cytochromes P450: role of metabolic intermediate complexes.

2005-04-15

[Arch. Biochem. Biophys. 436(2) , 265-75, (2005)]

The Kulinkovich reaction in the synthesis of constrained n,n-dialkyl neurotransmitter analogues.

2007-05-10

[Org. Lett. 9(10) , 1987-90, (2007)]

Mutation of surface cysteine 374 to alanine in monoamine oxidase A alters substrate turnover and inactivation by cyclopropylamines.

2005-05-16

[Bioorg. Med. Chem. 13(10) , 3487-95, (2005)]

More Articles...